Patents Assigned to REDBIOTEC AG
  • Means and methods for treating HSV
    Patent number: 11058765
    Abstract: The present invention relates to a vaccine composition comprising a multimeric complex of Herpes Simplex Virus (HSV) polypeptides for the treatment or vaccination against HSV. The present invention also relates to a vector comprising a polynucleotide encoding the HSV polypeptides and a host cell comprising the vector. The present invention further comprises a method for producing the vaccine composition.
    Type: Grant
    Filed: March 14, 2017
    Date of Patent: July 13, 2021
    Assignee: REDBIOTEC AG
    Inventors: Garyfalia Stergiou, Christian Schaub, Corinne John